These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6604030)

  • 1. Colistin and trimethoprim-sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukaemia. Decrease in the emergence of resistant bacteria.
    Rozenberg-Arska M; Dekker AW; Verhoef J
    Infection; 1983; 11(3):167-9. PubMed ID: 6604030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin for infection prevention in patients with acute leukemia.
    Rozenberg-Arska M; Dekker AW
    Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S45-7. PubMed ID: 3325929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.
    Dekker AW; Rozenberg-Arska M; Verhoef J
    Ann Intern Med; 1987 Jan; 106(1):7-11. PubMed ID: 3466563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-trimoxazole alone for prevention of bacterial infection in patients with acute leukaemia.
    Starke ID; Donnelly P; Catovsky D; Darrell J; Johnson SA; Goldman JM; Galton DA
    Lancet; 1982 Jan; 1(8262):5-6. PubMed ID: 6119443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of infection in acute leukemia: a prospective randomized study on the efficacy of two different drug regimens for antimicrobial prophylaxis.
    Kurrle E; Dekker AW; Gaus W; Haralambie E; Krieger D; Rozenberg-Arska M; de Vries-Hospers HG; van der Waaij D; Wendt F
    Infection; 1986; 14(5):226-32. PubMed ID: 3491791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection prophylaxis in acute leukemia. Comparative effectiveness of sulfamethoxazole and trimethoprim, ketoconazole, and a combination of the two.
    Estey E; Maksymiuk A; Smith T; Fainstein V; Keating M; McCredie KB; Freireich EJ; Bodey GP
    Arch Intern Med; 1984 Aug; 144(8):1562-8. PubMed ID: 6087753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Another look at trimethoprim-sulfamethoxazole: its role in parenteral therapy.
    Sattler FR; Remington JS
    Eur J Clin Microbiol; 1984 Jun; 3(3):174-6. PubMed ID: 6332015
    [No Abstract]   [Full Text] [Related]  

  • 8. Trimethoprim-sulfamethoxazole.
    Cockerill FR; Edson RS
    Mayo Clin Proc; 1987 Oct; 62(10):921-9. PubMed ID: 3498863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral trimethoprim/sulfamethoxazole in attempt to prevent infection after induction chemotherapy for acute leukemia.
    Henry SA; Armstrong D; Kempin S; Gee T; Arlin Z; Clarkson B
    Am J Med; 1984 Oct; 77(4):663-6. PubMed ID: 6435446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulphonamides and trimethoprim.
    Reeves D
    Lancet; 1982 Aug; 2(8294):370-3. PubMed ID: 6124767
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia.
    Wade JC; Schimpff SC; Hargadon MT; Fortner CL; Young VM; Wiernik PH
    N Engl J Med; 1981 Apr; 304(18):1057-62. PubMed ID: 6782486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of bacterial infections in granulocytopenic patients.
    Henry SA
    Am J Med; 1984 Apr; 76(4):645-51. PubMed ID: 6369979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia.
    Dekker AW; Rozenberg-Arska M; Sixma JJ; Verhoef J
    Ann Intern Med; 1981 Nov; 95(5):555-9. PubMed ID: 6794406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of infection in patients with acute nonlymphocytic leukemia by several drug treatment regimens.
    Verhoef J; Rozenberg-Arska M; Dekker A
    Haematol Blood Transfus; 1987; 30():188-93. PubMed ID: 3114058
    [No Abstract]   [Full Text] [Related]  

  • 15. Trimethoprim-sulfamethoxazole.
    Hughes WT
    Pediatr Clin North Am; 1983 Feb; 30(1):27-30. PubMed ID: 6600834
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of trimethoprim-sulfamethoxazole to prevent bacterial infections in children with acute lymphoblastic leukemia.
    Goorin AM; Hershey BJ; Levin MJ; Siber GR; Gelber RD; Flynn K; Lew M; Beckett K; Blanding P; Sallan SE
    Pediatr Infect Dis; 1985; 4(3):265-9. PubMed ID: 3889875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimethoprim-sulfamethoxazole and trimethoprim alone for prophylaxis of infection in granulocytopenic patients.
    Gurwith M; Truog K; Hinthorn D; Liu C
    Rev Infect Dis; 1982; 4(2):593-601. PubMed ID: 6981175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-trimoxazole versus non-absorbable antibiotics in acute leukaemia.
    Watson JG; Jameson B; Powles RL; McElwain TJ; Lawson DN; Judson I; Morgenstern GR; Lumley H; Kay HE
    Lancet; 1982 Jan; 1(8262):6-9. PubMed ID: 6119459
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous sulfamethoxazole-trimethoprim: pharmacokinetics, therapeutic indications, and adverse reactions.
    Gleckman R; Gantz NM; Joubert DW
    Pharmacotherapy; 1981; 1(3):206-11. PubMed ID: 6985449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid.
    Wade JC; de Jongh CA; Newman KA; Crowley J; Wiernik PH; Schimpff SC
    J Infect Dis; 1983 Apr; 147(4):624-34. PubMed ID: 6842003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.